TAKEDA PHARMACEUTICAL CO LTD - 14 Mar 2022 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role: 10%+ Owner
Signature: /s/ Amit Singh, Senior Vice President and Head of Treasury of Takeda Pharmaceutical Company Limited
Issuer symbol: PHAT
Transactions as of: 14 Mar 2022
Net transactions value: -$342
Form type: 4
Filing time: 16 Mar 2022, 20:10:18 UTC
Previous filing: 09 Dec 2021
Next filing: 29 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PHAT	Common Stock	Exercise of in-the-money or at-the-money derivative security	$0	+7,359,304	+7359%	$0.000000	7,459,304	14 Mar 2022	Direct	F1
transaction	PHAT	Common Stock	Sale	$342	-18	-0%	$19.00	7,459,286	14 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PHAT	Warrants	Exercise of in-the-money or at-the-money derivative security	$0	-7,359,304	-100%	$0.000000^*	0	14 Mar 2022	Common Stock	7,359,304	$0.000000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 14, 2022, the Reporting Person exercised a Warrant to purchase 7,359,304 shares of the Issuers common stock with an exercise price of $0.00004613 per share. The Reporting Person paid the exercise price on a cashless basis in accordance with the terms of such Warrants, resulting in the Issuer withholding a number of shares (or portion thereof) to satisfy the exercise price and issuing to the Reporting Person the remaining number of shares. The Issuer also paid the Reporting Person $2.52 in lieu of a fractional share.

Content

On March 14, 2022, the Reporting Person exercised a Warrant to purchase 7,359,304 shares of the Issuers common stock with an exercise price of $0.00004613 per share. The Reporting Person paid the exercise price on a cashless basis in accordance with the terms of such Warrants, resulting in the Issuer withholding a number of shares (or portion thereof) to satisfy the exercise price and issuing to the Reporting Person the remaining number of shares. The Issuer also paid the Reporting Person $2.52 in lieu of a fractional share.